BeStock  
Stocks › Biotechnology › ORIC

Oric Pharmaceuticals ORIC

US equityMarket cap rank #3332Biotechnology
$7.36 −$0.34 (-4.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.37 +0.14%
Open$7.58
Prev close$7.70
Day range$7.28 – $8.00
Volume1.46M
Market cap$764.94M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.0x
CheapRich

Below its usual level · 26th percentile, 5-year average -4.7x

Price / book2.1x
CheapRich

Around its usual level · 56th percentile, 5-year average 2.0x

#3211 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-11x-8x-4x0xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$12.44
Price vs. fair value-40.9%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.14 – 2.05 56% (pricier than usual) #3211 of 5329 (1 = cheapest)
PE -6.05 -4.37 -4.67 26% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ORIC.

Sign in to join the discussion.

Scroll to Top